The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by McDougle, C. J.
* Articles by Price, L. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by McDougle, C. J.
* Articles by Price, L. H.

Am J Psychiatry 1993; 150:647-649
Copyright © 1993 by American Psychiatric Association


BRIEF REPORTS

Limited therapeutic effect of addition of buspirone in fluvoxamine- refractory obsessive-compulsive disorder

CJ McDougle, WK Goodman, JF Leckman, JC Holzer, LC Barr, E McCance-Katz, GR Heninger and LH Price
Clinical Neuroscience Research Unit, Yale University School of Medicine, Connecticut Mental Health Center, New Haven 06519.

The authors found that buspirone added to the treatment of 33 patients with obsessive-compulsive disorder who were refractory to the serotonin reuptake inhibitor fluvoxamine was no better than placebo in reducing obsessive-compulsive, depressive, or anxiety symptoms. This finding suggests that addition of buspirone to ongoing fluvoxamine therapy is not an effective treatment strategy for most patients with obsessive- compulsive disorder.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
K. J Craig and N. A Fineberg
OCD and anxiety: from afterthought to independence
J Psychopharmacol, March 1, 2008; 22(2): 217 - 219.
[PDF]


Home page
FocusHome page
J. H. Greist and J. W. Jefferson
Obsessive-Compulsive Disorder
Focus, January 1, 2007; 5(3): 283 - 298.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
N. A. Fineberg, T. M. Gale, and T. Sivakumaran
A review of antipsychotics in the treatment of obsessive compulsive disorder
J Psychopharmacol, January 1, 2006; 20(1): 97 - 103.
[PDF]


Home page
FocusHome page
A. Kaplan and E. Hollander
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Focus, July 1, 2004; 2(3): 454 - 461.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
A. Kaplan and E. Hollander
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Psychiatr Serv, August 1, 2003; 54(8): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
R. Ramasubbu, C. J. McDougle, and L. H. Price
Antiobsessional Effect of Risperidone Add-On Treatment in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder May Be Dose-Dependent
Arch Gen Psychiatry, May 1, 2002; 59(5): 472 - 473.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
C. J. McDougle, C. N. Epperson, G. H. Pelton, S. Wasylink, and L. H. Price
A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor-Refractory Obsessive-compulsive Disorder
Arch Gen Psychiatry, August 1, 2000; 57(8): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. h. Greist, J. W. Jefferson, K. A. Kobak, D. J. Katzelnick, and R. C. Serlin
Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder: A Meta-analysis
Arch Gen Psychiatry, January 1, 1995; 52(1): 53 - 60.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
C. J. McDougle, W. K. Goodman, J. F. Leckman, N. C. Lee, G. R. Heninger, and L. H. Price
Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder: A Double-blind, Placebo-Controlled Study in Patients With and Without Tics
Arch Gen Psychiatry, April 1, 1994; 51(4): 302 - 308.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1993 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org